Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Altria Group Inc (MO) A Smoking Investment?

Altria Group (MO)Editor’s Note: This article contained inaccurate information regarding declines in Altria’s revenue and book value, and that information has been removed.

A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company and its future. As 2013 begins, I would like to focus on a leader in the United States tobacco industry: Altria Group Inc (NYSE:MO) Incorporated .


Dividend: Currently, Altria Group Inc (NYSE:MO) pays out quarterly dividends of $0.44, which when annualized puts the dividend as yielding 5.15%
Double Digit Margin: At the moment, the company carries a net profit margin of 20.40%, leaving plenty of room for unexpected expenditures
Institutional Vote of Confidence: 60% of shares outstanding are held by institutional investors, displaying the confidence some of the largest investors in the world have in the company and its future
Solid Net Income Growth: In 2008 Altria Group Inc (NYSE:MO) reported net income of $3.09 billion; in 2012, the company announced net income of $4.18 billion, representing year over year annual growth of 7.85%, despite experiencing negative revenue growth during this period, which represents a company with expanding margins (Not Profit Margin: 2008=16.0% 2012=23.9% 2015 Projected=29.3%)
Addictive Business Model: Altria Group Inc (NYSE:MO)’s products–cigarettes, smokeless products, cigars, and wine–are all extremely addictive to the users, which establish solid revenue streams for years to come


  • High Valuation: Currently, Altria carries a price to earnings ratio of 16.60, a price to sales ratio of 2.81, and a price to book ratio of 21.85; all of which indicate a company trading with a high valuation when the company’s growth prospects are taken into account
  • Unhealthy Offerings: All of the company’s offerings are unhealthy products, and have been proven to have a distinct link to users’ deaths, which is a major weakness of the company
  • Net Debt: Despite possessing $2.2 billion of cash and cash equivalents on their balance sheets, the company’s $14 billion debt load results in a net debt of $11.8 billion, which could be a potentially dangerous factor


Increasing Revenue per Cigarette: In 2008, Altria Group Inc (NYSE:MO) derived $0.111 of revenue from each cigarette; currently, the company derives $0.161 of revenue from each cigarette it sells, and further growth in this figure will benefit the overall company

Product Innovation: Offering innovative products could excite customers and capture market share, boosting revenue growth

Growth in the Smokeless Products Market: The United States smokeless products market is one of the fastest growing in the world, going from $1.18 billion in 2009 to $1.38 billion currently, and further growth in this market could result in revenue growth (15.95% of overall business is concentrated in the smokeless products segment)

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.